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Accurate identification of individuals at high risk of dementia influences clinical care, inclu-
sion criteria for clinical trials and development of preventative strategies. Numerous models
have been developed for predicting dementia. To evaluate these models we undertook a
systematic review in 2010 and updated this in 2014 due to the increase in research pub-
lished in this area. Here we include a critique of the variables selected for inclusion and an
assessment of model prognostic performance.
Methods
Our previous systematic review was updated with a search from January 2009 to March
2014 in electronic databases (MEDLINE, Embase, Scopus, Web of Science). Articles
examining risk of dementia in non-demented individuals and including measures of sensitiv-
ity, specificity or the area under the curve (AUC) or c-statistic were included.
Findings
In total, 1,234 articles were identified from the search; 21 articles met inclusion criteria. New
developments in dementia risk prediction include the testing of non-APOE genes, use of
non-traditional dementia risk factors, incorporation of diet, physical function and ethnicity,
and model development in specific subgroups of the population including individuals with
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diabetes and those with different educational levels. Four models have been externally vali-
dated. Three studies considered time or cost implications of computing the model.
Interpretation
There is no one model that is recommended for dementia risk prediction in population-
based settings. Further, it is unlikely that one model will fit all. Consideration of the optimal
features of new models should focus on methodology (setting/sample, model development
and testing in a replication cohort) and the acceptability and cost of attaining the risk vari-
ables included in the prediction score. Further work is required to validate existing models
or develop new ones in different populations as well as determine the ethical implications of
dementia risk prediction, before applying the particular models in population or clinical
settings.
Introduction
Dementia is a complex disease often caused by a combination of genetic and environmental
risk factors. Although many risk factors for the occurrence and progression of dementia have
been identified, their utility for determining individual risk through dementia prediction mod-
els remains unclear.
Numerous models for predicting dementia, and more specifically Alzheimer’s Disease
(AD), have been developed[1]. Such models could be used to refine inclusion criteria for clini-
cal trials, focus treatment and intervention more effectively and help with health surveillance.
A systematic review published in 2010 identified over 50 different dementia risk prediction
models[1]. The models differed in the number and type of variables used for risk score calcula-
tion, follow-up time, disease outcome and model predictive accuracy. The review concluded
that no model could be recommended for dementia risk prediction largely due to methodologi-
cal weaknesses of the published studies. Model development had generally been based on small
cohorts, restricted to Caucasians, and at the time of the review there had been a lack of objec-
tive and unbiased model evaluation, such as external validation.
Over the last five years, research into dementia risk prediction has greatly expanded and
dementia prevention is a high policy priority in many countries. In order for clinicians,
researchers and policy makers to keep up to date on relevant findings and make decisions
about which model to apply to identify those high risk of future dementia, it is necessary to
have an accurate knowledge of model development (including component variables and valida-
tion work), discriminative accuracy, and sensitivity and specificity of cut-off scores. In this
review, based on the results of an updated literature search, we aim to evaluate the latest devel-
opments in dementia risk prediction modelling including a critique of the variables selected for
model inclusion and an assessment of model prognostic performance.
Methods
Search Strategy
This review has been undertaken with adherence to the PRISMA statement[2]. MEDLINE,
Embase, Scopus and ISI Web of Science were searched using combinations of the following
terms and mapped to Medical Subject Headings (MeSH): “dementia”, “Alzheimer disease”,
“Alzheimer and disease”, “predict”, “develop”, “incident”, “sensitivity”, “specificity”, “ROC”
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and “area under the curve”. The search included all literature published between the 1 January
2009 to 17 March 2014 (see Table 1 for the search strategy). Only articles published in English
were considered. Additional articles were identified from the reference lists of eligible studies
and relevant reviews. All articles published from January 2009 –November 2009 were also
removed as this was covered in the original review.
Selection of Studies
Selection of articles followed the same protocol as the 2010 review[1]. Two authors (ET and
SH) independently searched publications using the following inclusion criteria: the sample was
population-based and the article examined risk of dementia in non-demented individuals and
included measurements of sensitivity, specificity or discrimination (i.e., area under the curve:
AUC or c-statistic). Cross-sectional, case-control and clinical-based studies were excluded, as
were studies that restricted the baseline sample by cognitive criteria other than dementia status;
for example studies were excluded that focused only on subjects with Mild Cognitive
Impairment (MCI). Articles where the outcome was a combined cognitive group, for example
dementia cases combined with individuals with MCI, were also excluded. Titles and abstracts
were searched first, followed by the full text of any identified articles. Where duplicate studies
were identified, details of all novel risk models and their performance indices (AUC/c-statistic,
sensitivity or specificity) were extracted from each publication and reported separately. One set
of duplicate publications was found[3, 4]. However, the first paper[3] only presented the model
and did not undertake testing. This paper was therefore excluded. Disagreements were solved
by consensus between the two authors (ET and SH), or by a third author (BCMS) if the dis-
agreement could not be resolved.
Data Extraction
Two authors (ET and SH) independently extracted information from each study including:
sample, country, length of follow-up, baseline age, sex distribution, outcome tested (e.g., all-
cause dementia vs. dementia subtypes), the components of each prediction model,







7. "sensitivity and specificity"
8. 2 or 3 or 4 or 5 or 6 or 7
9. receiver operating characteristic
10. ROC.mp.




15. 9 or 10 or 11 or 12 or 13 or 14
16. 1 and 8 and 15
17. limit 16 to yr = "2009-Current"
doi:10.1371/journal.pone.0136181.t001
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discriminative accuracy (AUC or c-statistic), and where available, sensitivity and specificity
estimates of cut-off scores and positive/negative likelihood ratio (LR+ or LR-, respectively).
Two authors (ET, SH) independently assessed the quality of the included studies using an
adapted version of the Newcastle-Ottawa Scale (NOS) for non-randomized studies, specifically
cohort studies[5], as endorsed by the Cochrane collaboration [6]. The NOS uses a star rating
system to assess selection, comparability and outcome criteria. Items describing a non-inter-
vention cohort were excluded and therefore the total ranking was out of 6 (rather than 9).
Results
Included Studies
A total of 1,234 articles were identified from the electronic literature search (after removing
duplicate publications) and 11 articles were identified from other sources. In total, 21 articles
describing dementia risk prediction models were included in this review (Fig 1).
Table 2 summarises the study characteristics and predictive models. 13 new study popula-
tions[7–20] have been used to create risk models compared to the first review (all literature till
2009)[1]. There was however some overlap including use of data from the Cardiovascular
Health Cognition Study[20, 21], Leipzig Longitudinal Study of the Aged (LEILA 75+)[22], Ein-
stein Aging Study[23], Vienna TransDanube Aging[24], Canadian Study of Health and Aging
[25] and the Kungsholmen Project[4]. Sample sizes ranged from 194[11] to 29,961[13]. Follow-
up duration ranged from 1.4[22] to 20 years[7]. Follow-up rate ranged from 66%[12] to 86%
[19], with 10 studies[4, 7, 11, 14, 15, 17, 20, 21, 23, 25] not reporting attrition or dropout. In ten
studies[7, 10, 12–14, 16, 20–22, 26] the outcome tested was all-cause dementia, in nine studies
[8, 9, 11, 15, 17–19, 23, 24] the outcome was AD and two studies had separate models for both
AD and all-cause dementia [4, 25]. The number of predictors ranged from one[22] to 19[25].
Quality Assessment
Articles were assessed on selection, comparability and outcome (out of a maximum of six
stars). In total, six[8, 13, 16, 18, 19, 26] articles scored six stars (maximum), 13 scored five stars
[4, 7, 9–12, 14, 15, 17, 20, 22–24] and two[21, 25] scored four stars. This indicates that most
articles were of high or moderate quality. Star ratings for each article are shown in Table 2.
Model Development
Most models have been derived using Logistic Regression[7, 9, 10, 21, 24–26] or Cox Propor-
tional Hazards Regression analysis[8, 11, 13, 15–20, 22, 23], usually using stepwise selection to
identify candidate predictors (e.g., based on a p-value; forwards or backwards), with one model
using the Bayesian Information Criterion[19]). One model, the Australian National University
Alzheimer’s Disease Risk Score (ANU-ADRI), was developed using an Evidence-Based Medi-
cine Approach rather than through a data analytical approach[4] and another, the Brief
Dementia Screening Indicator (BDSI) was developed using data synthesis based on the best
dementia predictors identified in four different cohort studies[20]. When computed, simple
risk scores have been derived from the model’s Beta-[4, 13, 16, 19, 20] or logit-coefficients[21].
This is similar to the methodology employed for risk model development in other fields of
medicine such as cardiovascular disease[27, 28]. No models have yet been developed using sys-
tems biology or neural network approaches. Neural networks simulate the functions of neurons
of human brains which can interact for processing data and learning from experiences [29].
Given the potential complexity of the risk factor variables used in dementia risk prediction,
neural networks may also hold promise although this has yet to be evaluated.
Developments in Dementia Risk Prediction Models: A Systematic Review
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Risk Models
Models can be broadly divided into the following categories: (1) demographic only models; (2)
cognitive based models (incorporating cognitive test scores, with or without subjective mem-
ory/cognitive complaint indicators or demographic data); (3) health variables and health risk
indices (incorporating self-reported or objectively measured health status); (4) genetic risk
scores including APOE, PICALM (Phosphatidylinositol binding clathrin assembly protein),
CLU (Clusterin) and other genes associated with AD (i.e., BIN1, CR1, ABCA7, MS4A6A,
MS4A4E, CD2AP, EPHA1 and CD33), either alone or in combination with non-genetic vari-
ables; and, (5) multi-variable models typically incorporating demographic, health and lifestyle
measures. Table 3 shows comparisons of the model components between this and the 2010
Fig 1. PRISMA (2009) flow diagram of article selection.
doi:10.1371/journal.pone.0136181.g001
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Difficulty remembering recent events &/or difficulty
remembering short list of items (Informant reported)
Self-reported difficulty with short-term memory (“Do you
frequently have difficulties in retaining or remembering
new simple information?”)
Self-reported trouble “keeping mind on things” >3 days/week Self-reported “trouble keeping mind on things” >3 days/
week
Subjective memory complaint Subjective memory impairment (‘‘Do you feel like your
memory is becoming worse?”—with and without worry)
Functioning Time to put on and button a shirt IADL scale
IADL score (Four items: using the telephone, managing
treatment, handling finances, and using transportation)
IALD item “Does your patient need help from others to
manage money or medications?”
Neuropsychological Tests Activity Recall (recall of all tests worked on during the
interview)
ADAS-Cog Battery (Word Recall, Command,
Construction, Naming, Ideation Praxis, Orientation, Word
Recognition, Remembering Instructions, Spoken
Difficulties, Word Finding, Comprehension,
Concentration)
ADAS-Cog (word not recalled) Benton Visual Retention Test (Form F MQ)
Block Design (Wechsler Adult Intelligence Scale-Revised) CAMCOG (Total score, Memory (Remote, Recent,
Learning, composite score), Non-memory (Orientation,
Language Comprehension, Language Expression,
Attention & Calculation, Praxis, Abstraction, Perception,
composite score))
Boston Naming Test (subtests) CERAD Battery (Total score, Constructional Paraxis
Recall, Word List Learning, Word List Recall, Boston
Naming Test)
Buschke Selective Reminding Test Clock Drawing Test
CAMCOG (Total score, Memory, General Knowledge,
Attention & Calculation)
Copying (intersecting pentagons)
CASI (Total score, Semantic Memory, Episodic Memory,
Attention, Concentration/Mental Manipulation, Orientation,
Visual Construction, Abstraction & Judgment)
Delayed Recall (3 words)
Clock drawing Digit Symbol Substitution Test
Clock setting Free and Cued Selective Reminding Test (Free recall
score, Total recall Score)
Clock reading Instruction (Paper folding)
Copying (cube, coils and interlocking infinity loops) Isaacs Set Test
Digit Letter Test Logical Memory I (Immediate Recall)
Digit Symbol Substitution Test MMSE (Total score, Episodic Memory Subtest)
Free and cued recall of recognisable words Rey-Auditory Verbal Learning Test (Short delayed recall
score)
Free and Cued Selective Reminding Test Stroop Test
Free recall of rapidly and slowly presented random words Trail Making Test (Part A and B)
Fuld Object Memory Evaluation (FOME) Recall Test Vascular Dementia Assessment Scale Cognitive Battery
(Delayed recall of the ADAS-Cog 10 Word Lists, Symbol
Digit Test, Digit Span Backwards, A Maze Task, Digit
Cancellation Task, Animal Naming)
Identical Pictures Verbal Fluency (Animals)
Intra-categorical Delayed Selective Reminding Test (IDSR-7) Wechsler Memory Scale Information Subtest
List-generating fluency
(Continued)
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Table 3. (Continued)
Memory for Text
Memory Scale Information Subtest (WAIS)
Mini Mental State Examination (MMSE)
Modified MMSE (3MS: total score and individual items)
Paired-Associate Learning Test
Rey-Auditory Verbal Learning Test (Short delayed recall score)
Reid Memory Test
Rey Figure (Delay recall)
Screening Instrument for Cognitive Impairment & Dementia
Similarities (Subtests)
Trail Making Test (Part B)
Verbal Fluency (animals, fruits, flowers vegetables, groceries,
letters: ‘ta’, F, A and S)
Vocabulary subtest of WAIS
Health (Objective and Self
Reported)
Angina Acute metabolic events (severe hyperglycaemic or
hypoglycaemic events)
Aortic calcification Anti-hypertensive agents
Arthritis Arthritis or rheumatism
Atrial fibrillation Body Mass Index
Body Mass Index Carotid endarterectomy
Calf pain when walks, ceases when halts Central obesity
Chest pain when excited Cerebrovascular attacks
Chest pain when walking up hill or fast Chest problems
Chronic heart failure Cholesterol
Chronic obstructive pulmonary disease Congestive heart failure
Claudication Coronary artery bypass surgery/graft
Coronary artery bypass surgery Cough
Defective ventricular conduction Dental problems
Depression Denture fit
Diabetes Depressed mood
Dizziness when suddenly stands up Depression
Extrapyramidal score (including measures of tone (rigidity,
cogwheeling, nuchal rigidity), bradykinesia (slowed fine finger
movements, reduced arm swing, and an overall clinical
assessment of the presence of bradykinesia), resting tremor,
postural flexion, and the glabella tap)
Depressive symptoms (including CES-D and DSM-III-TR
Classification A1: depressed mood, A2: loss of interest,
A3: change of appetite, A4: sleep disturbance, A5:
psychomotor change, A6: loss of energy, A7:
worthlessness, A8: concentration difficulty)
Heart disease Diabetes
Hypercholesterolaemia (self-reported) Diabetic foot
Hypertension (including hypertension currently treated) Ear trouble
Internal carotid artery thickness Eye trouble
Myocardial infarction Eyesight trouble
Parkinson disease Feet or ankle trouble
Peripheral artery disease Fractures (any)
Pulmonary congestion Glycosylated haemoglobin (HbA1c)
Second heart sound abnormal Head trauma
Sinus tachycardia Hearing trouble
Stroke High density lipoprotein cholesterol level
Systolic blood pressure Hypertension
Transient ischaemic attack Incontinence (urinary: lose control of bladder and faecal:
lose control of bowels)
(Continued)
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Table 3. (Continued)
T-wave abnormalities Kidney trouble
Total cholesterol level Microvascular disease (diabetic retinal or end-stagerenal)
Myocardial infarction
Nose stuffed up or sneezing




























Statistics/Methodology Reliable change indices
Within persons across test variability
Other Family history of dementia (Informant report) Cognitive activity
Walking speed (5 meter returned walk) Clinical Dementia Rating Scale—Sum of Boxes (Clinician
& algorithm based)
International Working Group Consensus Criteria for Mild
Cognitive Impairment (MCI)
Self-reported Health (how good & report of any health
problems)
Social network and engagement
Abbreviations: ADAS-Cog Alzheimer's Disease Assessment Scale-cognitive; IADL Instrumental Activities of Daily Living; CAMCOG Cambridge
Cognitive Examination; CASI The Cognitive Abilities Screening Instrument; CERAD Consortium to Establish a Registry for Alzheimer’s Disease; CES-D
Center for Epidemiologic Studies Depression Scale; DSM-III-R Diagnostic & Statistical Manual of Mental Disorders–3rd Edition Revised; IDSR-7 Intra-
categorical Delayed Selective Reminding Test; MMSE Mini Mental State Examination; WAISWechsler Adult Intelligence Scale
doi:10.1371/journal.pone.0136181.t003
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review and illustrates that there is large variability in model components and differences across
the two reviews.
Differences are mainly in the addition of novel (non-traditional) dementia risk variables[25],
information on diet[4], depression symptomology[4, 13, 24], ethnicity[14, 20, 23], and extension
of genetic analysis to include non-APOE genes[17]. In addition, fewer cognitive tests are used
and there is a smaller pool of candidate risk factors, likely due to more evidence being available.
Model Diagnostics
Performance of models has been assessed using measures of discriminative accuracy (e.g., AUC/
c-statistic), sensitivity, specificity, positive predictive value (PPV), negative predictive value
(NPV), internal calibration, LR+/LR-, the net reclassification index (NRI) and the integrated
discrimination improvement (IDI) statistic. Discriminative accuracy was measured in all studies
and ranged from low 0.49[4] to moderate 0.89[9]. Cut-off points with sensitivity and specificity
estimates were only reported in five studies[7, 19, 22, 23, 26]. Where available, cut-off points
were determined as follows: (1) maximisation of Youden’s index (Formula = Sensitivity + Speci-
ficity– 1)[22, 23, 26]; (2) computed by cross validation to correct for optimism as a result of vali-
dation on the learning data to correspond to a sensitivity value[7]; or, (3) defining the cut-off
scores as those values with high specificity and increased PPV[19]. No model reported a cut-off
score with both sensitivity and specificity over 80%. Three studies reported PPVs: (1) 9 to 41%
(range across different length of follow-up interval and educational level)[7]; (2) 6.6 to 49.9%
(range across different cut-off scores)[23]; and, (3) 14.7% with a cut-off that provided sensitivity
of at least 80%[19]. Two studies reported NPVs: range across different cut-off scores: 86.0 to
99.0%[7] and 97.7%[19]. NPV should be higher than the proportion of subjects who did not
have the outcome of dementia (i.e., the “stable” subjects), if the prediction is better than chance.
Table 4. Optimum features of study design and variables selected for dementia risk prediction
models.
Data & Data Analysis
Minimal attrition or use of methodology that accounts for attrition (e.g., loss of follow-up and death)
Considerations of the description of population, diagnostic method and follow-up time
Examine internal validity (i.e., equivalent performance in different subgroups)
External validation
High AUC/c-statistic (closer to 1 the better)
Consideration of whether to prioritise sensitivity or specificity and the implications of doing so
Data Presentation
Sensitivity and specificity given at multiple cut-off points
Confidence Intervals of each statistic and if comparisons are made, use of a formal method of statistical
inference
Risk Factor Timing
Special attention to mid-life risk factor ascertainment in older subjects (e.g., risk factors for dementia in mid-
life may not be associated with dementia in older subjects)
Patient Acceptability
Risk variable attainment (e.g., cost and ease of acquisition of the data from a patient as well as health care
provider point of view)
Risk score calculation (acceptability to the patient/health care provider)
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Since the proportion of subjects not becoming demented was generally>85% (and always
>70%)–as inferred from Table 2 –a high NPV is expected, because the number depends on the
prevalence of the disease in the sample. The same logic can be applied to PPV. It should be
noted that because the proportion of subjects becoming demented (or not) varies among the
populations, variations in PPV and NPV do not necessarily reflect differences in performance of
the models. Only one study[26] reported LR+/LR- and found that a neuropsychological predic-
tion model provided a clinically important change in pre- to post-test probability of converting
to dementia (all cause) over 5 and 10 years follow-up.
Model calibration was rarely reported, and where reported indicated good fit[13, 14, 20].
Reclassification indices including NRI and the IDI statistics that test the addition of variables
to risk models, were used in two studies[14, 15]. The first study evaluated the influence of the
APOE genotype on the accuracy of AD risk assessment using NRI and found a significant
improvement (NRI 0.18, ZNRI = 2.47, P = 0.01) compared to a non-APOE model; the IDI was
Fig 2. Comparison of AUC indices in development vs. validation cohorts across different dementia risk prediction models. Key: BDSI, Brief
Dementia Screening Index; CAIDE, Cardiovascualr Risk Factors, Aging and Dementia; CHS, Cardiovascular Health Study; CVHS, Cardiovascular Health
Cognition Study; DSDRS, Type-2 Diabetes Specific Dementia Risk Score; FHS, Framingham Heart Study; KP, Kungsholmen Project; KPNC, Kaiser
Permanente Medical Care Program of Northern California; MAP, Rush Memory and Aging Project; PS-W, Pathways study cohort fromWashington; Pts,
Points; SALSA Sacramento Area Latino Study on Aging. References [1] Anstey KJ, Cherbuin N, Herath PM, Qiu C, Kuller LH, Lopez OL, et al. A Self-Report
Risk Index to Predict Occurrence of Dementia in Three Independent Cohorts of Older Adults: The ANU-ADRI. PLoS One. 2014;9(1):e86141; [2] Exalto LG
QC, Barnes D, Kivipelto M, Biessels GJ, Whitmer RA. Midlife risk score for the prediction of dementia four decades later. Alzheimers Dementia. 2013; [3]
Exalto LG, Biessels GJ, Karter AJ, Huang ES, KatonWJ, Minkoff JR, et al. Risk score for prediction of 10 year dementia risk in individuals with type 2
diabetes: a cohort study. The Lancet Diabetes and Endocrinology. 2013; [4] Barnes DE, Beiser AS, Lee A, Langa KM, Koyama A, Preis SR, et al.
Development and validation of a brief dementia screening indicator for primary care. Alzheimers Dementia. 2014:S1552-5260.Notes * No development
dataset. Rather, model tested in different cohorts.
doi:10.1371/journal.pone.0136181.g002
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estimated as 6.25 (ZIDI = 3.75, P<0.001)[15]. The second used NRI and IDI to assess the
improvements in performance of the Cardiovascular Risk Factors, Aging and Dementia
(CAIDE) risk score by adding new risk factors[14]. Here, both the NRI and IDI showed no
model improvements with the additional variables.
Models for Specific Subgroups of Individuals
One study developed a risk score, the Type-2 Diabetes Specific Dementia Risk Score (DSDRS),
for predicting 10-year incident dementia, in a primary care setting, in a large cohort of individ-
uals (N = 29,961) with type II diabetes[13]. The model incorporated age, education, microvas-
cular disease, diabetic foot, cerebrovascular disease, cardiovascular disease, acute metabolic
event and depression and was well calibrated and externally validated with moderate levels of
predictive accuracy (AUC = 0.74 development cohort vs. AUC = 0.75 validation cohort). In
another study, model development was undertaken in a sample stratified by education level
(low: no elementary school diploma vs. high: secondary school or university) and follow-up
time (3 vs. 10 years)[7]. This resulted in four different models that varied by education and
length of follow-up as shown in Table 2.
Model Validation
Only four studies have undertaken validation[4, 13, 14, 20]. Differences between the AUCs in
the development and validation cohorts for the different models tested are shown in Fig 2.
CAIDE. The CAIDE model was developed in sample of participants from Finland
(N = 1,409, age range: 39 to 64 years) and uses risk factors in midlife to estimate an individuals’
risk of later life dementia (mean follow-up time = 20 years). The model incorporates age, edu-
cation, sex, cholesterol level, BMI and systolic blood pressure (with and without APOE e4 sta-
tus)[30]. Using data from the Kaiser Permanente (n = 9,480; age range: 40 to 55 years; mean
follow up-time = 36.1 years) a similar AUC to the original study was reported (0.75 validation
vs. 0.78 original cohort)[14]. Furthermore, when the Kaiser Permanente sample was stratified
by ethnicity the CAIDE model was found to predict dementia well across different ethnicities
including Asian (AUC = 0.81), Black (AUC = 0.75) and White (AUC = 0.74). These estimates
are comparable to those reported in the original publication (model development dataset
AUC = 0.78)[30]. This study also attempted to improve the discriminative accuracy of the
CAIDE score with the addition of new variables such as central obesity, depressed mood, dia-
betes, head trauma, poor lung function and smoking but no significant improvement was
shown[14].
When using the CAIDE risk score for predicting dementia in three older aged cohorts, the
Rush Memory and Aging Project, the Kungsholmen Project and the Cardiovascular Health
and Cognition Study, validation was found to be poor (AUC range all-cause dementia: 0.49 to
0.57; AUC range AD: 0.49 to 0.57)[4]. Interestingly, excluding BMI or BMI and cholesterol
level together, modestly increased discriminative accuracy for all-cause dementia (AUC range:
0.55 to 0.60) and AD (AUC range 0.55 to 0.58)[4]. This result suggests that these variables may
not be as important for predicting dementia in later vs. midlife. Indeed, in some studies of
older aged cohorts higher BMI, cholesterol levels and blood pressure are found to be protective
against dementia[31]. Therefore, poor transportability of the CAIDE model to these three
cohorts may be due to the fact that the development dataset was a midlife cohort and the vali-
dation datasets were from older aged cohorts (Mean at baseline range: 72.3 to 81.5 years). The
results could also be due to attrition rates as only 3% were lost to follow-up in the original
study[30] compared to more than 20% of participants being lost in the three validation cohorts
[4].
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ANU-ADRI. Using an evidence synthesis approach to model development, the ANU-A-
DRI model was developed to assess a persons’ risk for later life AD (i.e., over 60 years of age)
based on exposure to 11 risk and four protective factors including: age, education, sex, BMI,
diabetes, depression, cholesterol, traumatic brain injury, smoking, alcohol use, physical activity,
pesticide exposure, social engagement, cognitive activity, and fish intake. Validation of the
ANU-ADRI[4] score produced moderate levels of discrimination for dementia when between
eight to 10 of the different risk/protective variables were mapped across three studies (AUC
range: 0.64 to 0.74). The studies included the Rush Memory and Aging Study (N = 903), the
Kungsholmen Project (N = 905) and the Cardiovascular Health Cognition Study (N = 2,496).
The variables mapped included: demographic (age, gender, education), health (diabetes, trau-
matic brain injury, depressive symptoms), cognition (cognitive activity) and lifestyle factors
(social network and engagement, smoking, alcohol, physical activity). When only common var-
iables from all cohorts were used (n = 6 variables including: age, sex, education, diabetes, smok-
ing, alcohol) the AUCs were: 0.69 (95% CI 0.65 to 0.73), 0.68 (0.63 to 0.70) and 0.73 (0.71 to
0.76) in the Rush Memory and Aging Study, the Kungsholmen Project and the Cardiovascular
Health Cognition Study, respectively. The authors did not test whether the differences in
AUCs when common variables were mapped across the different cohorts were statistically sig-
nificant. These results are interesting and raise the question as to whether all or just some risk
factors are needed to accurately predict future disease. It should be noted that one explanation
for differences in AUC estimates could be variation in age. In particular the Kungsholmen
Project, which included participants born before 1912 (baseline age> 75), was older than the
other two samples (Rush Memory and Aging Study baseline age> 53, Cardiovascular Health
Cognition Study> 65). The study also investigated the effect of gender on discriminative accu-
racy of the ANU-ADRI within each cohort and found only slight differences: the reported 95%
CIs for males and females overlapped suggesting that any differences in discriminative accu-
racy were not significant.
BDSI. The BDSI was developed with a three-step approach in four cohort studies includ-
ing: the Cardiovascular Health Study, Framingham Heart Study, Health and Retirement Study,
and the Sacramento Area Latino Study on Aging[20]. First, a list of potential predictive factors
available in most or all cohorts was identified. Second, in each cohort, variables most predictive
of dementia at six years were identified independently. Third, a subset of variables that were
consistently found in all four cohorts was identified and used in the model including demo-
graphics (age, education), health (history of stroke, diabetes mellitus, BMI, depressive symp-
toms) and lifestyle (assistance needed with money or medications) factors. The c-statistic for
predicting 6-year incident dementia varied between the 4 cohorts from 0.68 to 0.78. Sensitivity
analyses, using data from the Health and Retirement Study and Cardiovascular Health Study,
suggested that discrimination was good across different race/ethnic groups: Health and Retire-
ment Study (c-statistic = 0.75 Whites, 0.70 Blacks, 0.71 Latinos) and the Cardiovascular Health
Study (c-statistic = 0.70 Whites, 0.65 Blacks)[20].
Cost Considerations
One study considered the impact on discriminative accuracy of modifying the calculation of a
resource intensive risk score to incorporate less expensive measures. The original resource
intensive model, the Late Life Dementia Risk Index, included demographic (age), lifestyle
(alcohol consumption), neuropsychological (Modified Mini Mental State Examination
(MMSE) score and Digit Symbol Substitution Score), medical (history of coronary bypass sur-
gery and BMI), physical functioning (time to put on and button a shirt in seconds), genetic
(APOE), cerebral magnetic resonance imaging (MRI) (white matter disease and enlarged
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ventricles), and carotid artery ultrasound (internal carotid artery thickness>2.2mm) measures,
and had good discrimination for the prediction of 6-year incident dementia (c-statistic = 0.81,
95%CI: 0.79 to 0.83)[32]. The revised model, the Brief Dementia Risk Index, incorporated age,
neuropsychological testing (3 word delayed recall, interlocking pentagon copying, verbal
instructions (paper taking and folding), four legged animal naming task (30 seconds)), self-
reported attention difficulties (3 or more days per week in the last month), medical history
(stroke, peripheral artery disease, or coronary artery bypass surgery and BMI) and alcohol con-
sumption and had a significantly lower discriminative accuracy (c-statistic = 0.77, p<0.001),
but was able to categorize subjects as having low, moderate, or high risk of dementia with simi-
lar accuracy compared to the more resource intensive score[21].
Discussion
The results from the review show that many new models for dementia risk prediction have
been developed over the last five years. There have also been significant changes to the types of
variables used when compared to the previous review. However few studies have addressed the
issues of external validation and cost in using the risk model.
Strengths and Limitations
The strengths of this review are its systematic approach and inclusivity. There are some limita-
tions. It is difficult to synthesise the literature on dementia risk prediction due to the large vari-
ability across studies in follow-up length (range: 1.5 years[9] to 17 years[15]), sample age
(range: 40 to 99 years), outcomes tested (e.g., AD vs. all-cause dementia vs. dementia subtypes,
quality of the diagnosis), source of population (volunteer vs. population representative) and
the different variables incorporated into the prediction models. As such a meta-analysis was
not possible. Furthermore, any meaningful conclusions for population screening are limited by
the lack of cost-effective analysis and limited assessment of model transportability.
Clinical Implications
There is currently a clinical drive towards timelier diagnosis particularly in developed countries
such as the UK with the introduction of primary care direct enhanced services looking to iden-
tify those at risk of developing dementia e.g. stroke, diabetes, cardiovascular disease[33]. A risk
prediction tool, particularly in at risk populations such as diabetes[13] could further enhance
existing services. However, if model development in the field of dementia continues at its cur-
rent pace and if dementia risk prediction is found to be useful and cost-effective, then research-
ers and possibly clinicians will face difficult choices regarding which model to apply,
particularly as study comparison is difficult.
Variables in the Prediction Models and Comparison to Results from the First Review.
Compared to the earlier review [1] elements common to the majority of risk scores include age,
education, measures of cognition and health. However, new developments in dementia risk
prediction include non-APOE genes and genetic risk scores[17, 18], testing of non-traditional
dementia risk factors[25], incorporation of information on diet[4], physical function[4], physi-
cal activity/exercise and ethnicity[16] into risk modelling, and model development in specific
subgroups of the population (e.g., individuals with diabetes[13] and those with low vs. high
educational attainment[7]) and over different follow-up times. Furthermore, fewer cognitive
tests have been used in prediction models, reflecting our increasing knowledge of risk and pro-
tective factors. Despite the dramatic increase in the number of models and novel risk scores,
discriminative accuracy has not changed to a significant degree when compared to the previous
review (range in the 2010 review: 0.49 to 0.91 vs. range in this review: 0.49 to 0.89). Aside from
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cognitive based models, generally, the best models are those that incorporate multiple risk fac-
tors across different variable categories (e.g., demographic, cognition, physical and health).
Within the limits of our relatively limited knowledge of the genetic factors that influence
dementia risk, where statistically tested, addition of novel (non-APOE) risk factors to predic-
tion models do not appear to significantly increase discriminative accuracy[17]. In contrast,
the APOE genotype, at least in some studies, appears to be informative. Future work into poly-
genic risk scores would help.
Further there has been a drive towards more accessible and potentially modifiable variables.
Modifiable variables are important as they have the potential to be specifically targeted in pri-
mary or secondary prevention. There is now also evidence that around a third of AD cases
worldwide may be due to modifiable risk factors [34]. With risk models likely to be used in the
primary care setting, the availability of imaging variables may be difficult to obtain nor do they
significantly improve discrimination in prediction of dementia beyond the more readily pub-
lished multifactorial models [35].
Stratified Analyses
Results from stratified analysis suggest that unique dementia risk prediction models may need
to be developed depending on follow-up length (e.g., BMI and hypertension may be more
important in mid-life compared to later life models)[7, 23, 26, 36–38], an individual’s education
level (found in one study and requires replication) [7], health status (e.g., diabetes)[13], APOE
status[23] and the outcome tested (e.g., most studies focus on all-cause dementia and different
models maybe needed depending on dementia subtype)[19]. Further research is required to
develop risk models in samples stratified by other confounding factors known to influence the
timing and presentation of dementia symptoms (such as mid vs. later life) as well as investigate
the interactions between different risk variables (e.g., such as AOPE status and age).
Model Transportability
Before a risk prediction tool can be used in clinical practice or for research, transportability of
the model outside the cohort from which it was developed needs to be assessed. Only four stud-
ies have externally validated dementia risk prediction models and the results were mixed[4, 13,
14, 20]. The DSDRS model was developed and validated with moderate but similar levels of
discrimination (AUC 0.74 development vs. 0.75 validation)[13]. This is in comparison to the
CAIDE score (originally developed for midlife), which was poorly validated in three separate
(older) cohorts (AUC 0.77 development vs. AUC range 0.49–0.57 validation)[4]. However, it is
important to note that in this validation of the CAIDE score rather different populations were
used, that varied by age (mid vs. later life). Indeed, factors like higher BMI, blood pressure and
cholesterol levels are associated with lower incidence of dementia in the oldest old [31]. In con-
trast, the CAIDE score was found to transport well when the test population better resembled
the original population (i.e., was a mid-life cohort)[14]. Generally, external validation is diffi-
cult largely due to the lack of available cohorts with which to test models in terms of follow-up
times, data collected, age groups and risk variable measurement.
Most studies have been developed in datasets from North America (N = 12 studies), with
others developed in the UK (N = 1), Japan (N = 1), Austria (N = 1), the Netherlands (N = 2),
Pan-Europe (N = 1), Germany (N = 3) and France (N = 1). Whether the different models are
applicable across countries that vary by health and wealth is not known. Further, no models
have been developed for predicting other dementia sub-types, such as vascular dementia or
dementia with Lewy Bodies or for predicting different disease severity (e.g., mild, moderate
and severe dementia). This may have implications for treatment options.
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Issues Around Cost
The ability to assess the relative cost of calculating the different risk models and compare this
against the model’s accuracy will significantly influence recommendations about possible pro-
tocols for screening for dementia risk. Further, the incorporation of readily accessible primary
care related factors would be most useful for application within clinical and population based
settings. Three studies [4, 20, 21] have considered time and/or financial implications in risk
score calculation. However, in one study it was found that reducing the cost of risk score com-
putation by removing the need for MRI, ECG and detailed neuropsychological measures and
replacing them with less resource intensive variables (e.g., more detailed self-reported health
history and simple cognitive test items) resulted in a significant decline in discriminative accu-
racy[21, 32]. Thus raising the issue of what is the best information and minimum data set
needed for accurate dementia risk prediction. It is important to note that current models have
not yet utilized cerebrospinal fluid or positron emission tomography data as recommended for
classifying AD and its preclinical stages in new (clinical and research) criteria for AD and its
preclinical/prodromal states[39, 40]. Although these factors can be used to assist dementia
diagnosis, the feasibility and acceptance of incorporating them into risk prediction models and,
particularly in population-based settings, would likely be low.
Conclusions
Before a risk assessment tool can be implemented we need to know its discriminative accuracy,
predictive value, cost-effectiveness, transportability (e.g., to particular populations, ages and
gender etc.), and the general availability of its variables (e.g., to enable cross-study comparison
and result verification). We must also consider the design implications of the model: Are we
interested in highly sensitive indicators of near term (i.e., 3-years) incidence of dementia?
What operating characteristics are optimal for longer-term (5–10 years) predictive models?
Are we contemplating a stratified approach, whereby low-cost screening identifies subjects
with higher risk for more detailed and costly assessments?
It is not possible to state with certainty whether there exists one model that can be recom-
mended for dementia risk prediction in population-based settings. This is largely due to the
lack of risk score validation studies. Consideration of the optimal features of new models
should largely focus on methodology (model development and testing) and the cost and
acceptability of deriving the risk factors. Further work is required to validate existing models or
develop new ones, as well as to assess their cost-effectiveness and ethical implications, before
applying the particular models in population-based or clinical settings. While it is difficult to
make a recommendation regarding which model, we nonetheless offer some recommendations
of the optimal features for new models (see Table 4).
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